Editing & Finishing | Steven Lee Typesetting | Shen Ruifan
Focusing on the development of sustainable development, life sciences, consumer technology and technology going global, Dongdian Technology now publishes the Dongdian Evening News every day to collect and sort out global industry information, hoping to pay attention to the development of global scientific and technological innovation with you and look forward to the new trend of industrial development!
sustainable development
Siemens Energy's first modular prefabricated cabin sea rising station with a maximum capacity of 1000 MW was shipped at sea
On August 21, the upper block of the first domestic maximum capacity 1000 MW modular prefabricated cabin sea rising pressure station built by Siemens Energy successfully left Qingdao Jiaozhou Bay and went to the site of the State Power Investment Shandong Peninsula South Offshore Wind Power Base U site located in the sea area south of Rushan Mountain on the Shandong Peninsula. Shandong Peninsula South Offshore Wind Power Base U Site Project is the first 66 kV offshore wind power project with a capacity of 1 million invested and developed by Shandong Energy Development Co., Ltd. According to the plan, after the completion of the project, the offshore wind farm can generate 2.7 billion kilowatt-hours of electricity per year after full capacity is connected to the grid, which can effectively replace 830,000 tons of standard coal and reduce carbon dioxide emissions by 2.155 million tons.
The 576-horsepower Kia EV6 GT is unveiled, its most powerful model
Kia America debuted the 576-horsepower EV6 GT performance crossover at The Quail, a North American motorsport gathering. The EV6 GT is Kia's most powerful production car to date, and its arrival marks a new era of electrification and the Kia brand. Based on the award-winning E-GMP modular platform, the EV6 GT elevates the conversation and expands the limits of electric performance vehicles. The EV6 GT raises the bar for performance in the already formidable EV6 series, with a dual-motor e-AWD powertrain that powers all four wheels. The energy-intensive 77.4 kWh nickel-cobalt-manganese (80/10/10) battery pack serves the front-mounted 160kW motor, which, combined with the rear 270kW motor, produces a combined power output of 430 kW (576 hp) and 546 lb-feet. Torque. The EV6 GT accelerates from 0 to 60 mph in 3.4 seconds and increases its top speed to 161 mph. In independent tests conducted by leading third-party AMCI, the EV6 GT outperformed the Ferrari Roma and the Lamborghini Huracan Evo Spyder RWD.
The world's first electric convertible supercar, the Barchetta B95, created by Automobili Pininfarina, opens an exciting new chapter in its history with the world's first all-electric convertible Super Barchetta – the stunning new B95 at Monterey Auto Week. The all-electric Super Barchetta is a masterpiece of design and technology – the simplicity of its sleek open body contrasts with refined technical details, underpinned by pure electric performance, offering a dramatic interpretation of classic racing. The world's first all-electric Super Barchetta is equipped with a high-capacity 120 kWh lithium-ion battery with a peak power of 1400 kW (1900 PS). Liquid-cooled and protected by a robust and lightweight carbon casing, the T-shaped battery pack can be charged with a DC fast charger of up to 270kW and can be fully charged at 20-80% in just 25 minutes.
A.O. Smith AI-LiNK helped households achieve the "dual carbon" standard, and Enough was awarded 40 million euros in series A financing for energy-saving and emission-reducing artificial food companies within the household scope
Recently, artificial food company Enough announced that it has raised 40 million euros in a new round of financing that is about to be completed. Founded in 2015, Enough feeds the fungus with sugar from renewable feedstocks through technology and then ferments it like beer is made. The company eventually developed a sustainable fungal protein called Abunda, which Enough says has a neutral flavor and meaty texture and is rich in protein and high fiber. Enough's protein is used to make plant-based meat, fish, and dairy products.
Life Sciences
Microsoft and Epic Expand AI Collaboration to Accelerate Generative AI's Impact in Healthcare Microsoft and Epic announced that they will expand their AI collaboration to pave the way for generative AI to bring generative AI to the forefront of healthcare. Microsoft's large-scale cloud computing and AI technologies are combined with Epic's deep understanding of the healthcare industry and clinical workflows to address many of the issues currently impacting clinicians. The two companies today announced an expanded strategic plan to bring AI to healthcare at scale, integrating conversational, environmental, and generative AI technologies across the Epic Electronic Health Record (EHR) ecosystem. Designed to accelerate the development of solutions for healthcare's most critical needs, the program will expand secure access to AI-driven clinical insights and management tools across a broad range of Epic modules to enhance patient care, improve operational efficiency, improve the healthcare experience, and support the financial integrity of the global healthcare system. See: https://cn.technode.com/post/2023-08-23/microsoft-and-epic-expand-ai-collaboration-to-accelerate-generative-ais-impact-in-healthcare-addressing-the-industrys-most-pressing-needs/
CARsgen collaborated with Meidner to evaluate CT041 in combination with mRNA cancer vaccine
CARsgen Pharmaceutical, an innovative CAR-T cell therapy company focused primarily on the treatment of hematologic malignancies and solid tumors, announced that it and Mederna Corporation (Nasdaq: MRNA) have launched a collaboration agreement to study the combined effects of Cochin's Claudin 18.2 CAR-T product candidate (CT041) with Meidner's investigational Claudin 18.2 mRNA cancer vaccine. CT041 (satricabtagene autoleucel) is an autologous CAR-T cell product of CARsgen Pharmaceutical, which is studying its potential for the treatment of gastric cancer, pancreatic cancer and other specific digestive tumors, and is currently conducting multiple clinical studies in China and North America. Medner is developing an experimental off-the-shelf mRNA cancer vaccine that encodes for the protein Claudin18.2 that targets the tumor-associated antigen. Under the agreement, the partners will conduct preclinical studies and phase I clinical trials to evaluate the efficacy of CT041 in combination with Medna's Claudin18.2 mRNA cancer vaccine.
The world's first small interference RNA cholesterol-lowering drug Leke (Enclan sodium injection) was approved in China
Novartis China recently announced that the cholesterol-lowering drug Loke (Encosram sodium injection) has been approved by the National Medical Products Administration of China as an adjunct therapy to the diet for the treatment of adult patients with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia, including: in patients who cannot achieve LDL-C (low-density lipoprotein cholesterol) goals after receiving the maximum tolerated dose of statin therapy, with statins, or in combination with statins and other lipid-lowering therapies, and in patients who are intolerant or contraindicated with statins, alone or in combination with other lipid-lowering therapies. As the world's first and currently the only small interfering RNA (siRNA) drug used to reduce LDL-C, Enclan sodium injection opens a new era of blood lipid management, helping cardiovascular doctors and patients to carry out long-term management of blood lipids in a more convenient and compliant way, and improve the quality of life of patients.
Academician Ge Junbo's team successfully completed the first NyokAssist high-risk PCI treatment supported by a new generation interventional pump
Recently, the team of Academician Ge Junbo of Zhongshan Hospital affiliated to Fudan University successfully completed high-risk percutaneous coronary surgery (HRPCI) for patients with three lesions, left main lesions with chronic total occlusive lesions of the anterior descending branch and low left ventricular ejection fraction with the support of a new generation of interventional artificial heart (NyokAssist, Xinqing Medical). The successful development of this high-risk PCI surgery has preliminarily confirmed the safety and efficacy of NyokAssist's® new generation interventional pump in assisting high-risk PCI surgery, representing the world's smallest interventional artificial heart officially entering the clinic, which is an important milestone. The patient preoperative evaluation of the poor pumping function of the heart, the complicated course of the disease, the high risk of surgery, the expert team assessed that hemodynamic disorders may occur during the operation, and the operation was assisted by mechanical circulation, and after the consent of the family, it was decided to use NyokAssist to carry out PCI surgery with the support of the new generation of interventional artificial cardiac circulation. The operation process is smooth, NyokAssist® is convenient to operate, the performance is excellent, the patient's blood pressure is stable during the operation, and the position of the interventional pump is good and stable according to the cardiac ultrasound. The postoperative interventional pump was successfully withdrawn, the patient got out of bed after 6 hours, there were no vascular complications, the postoperative patient recovered well, there were no obvious abnormalities in blood routine, liver and kidney function and other indicators, the postoperative arterial blood pressure was maintained at 130/80 mmHg, the postoperative cardiac ultrasound showed that the cardiac pumping function was significantly improved, and the patient was successfully discharged after 2 days.
Consumer technology
Baidu Robin Li: Wenxin Model 4.0 will be launched at the end of the year
Baidu released its second-quarter earnings report last night, with revenue of 34.1 billion yuan, a year-on-year increase of 15%; Net profit attributable to Baidu (non-GAAP) was 8 billion yuan, a year-on-year increase of 44%. According to the Economic Observer Network, in the earnings call, Baidu founder, chairman and CEO Robin Li's speech mainly revolved around Wen Xin's words. In the first half of this year, Baidu Wenxin model was updated to version 3.5, and Li Yanhong said that version 4.0 of Wenxin model will be launched by the end of the year. It is worth mentioning that Wen Xin Yiyan has not yet been officially launched and is still in closed beta. Mr. Li said Baidu was waiting for regulatory approval. There's no specific launch date yet, but he's optimistic about the regulatory environment.
GPT-3.5 Turbo introduces fine-tuning features to create your own ChatGPT chatbot
OpenAI announced on its official website that it has launched GPT-3.5Turbo fine-tuning capabilities and updated APIs, allowing enterprises and developers to use their own data to build exclusive ChatGPT based on business use cases. OpenAI claims that such customized models can meet or exceed GPT-4 capabilities on certain tasks. The company also said that GPT-4's fine-tuning capabilities will be available this fall. By fine-tuning, companies that use GPT-3.5 Turbo through OpenAI's APIs can make their models better at following instructions, such as having it always respond in a given language. Alternatively, they can improve the model's ability to format responses consistently (for example, to complete code snippets), as well as hone the "feel" of the model's output, such as its tone, so that it better fits the brand.
Orange Microelectronics completed a C+ round of financing of 200 million yuan, promoting the continuous innovation of high-speed optical communication DSP and high-speed SerDes chip industry
Orange Microelectronics is a scarce high-speed optical communication DSP chip provider in China, with 100% intellectual property rights of high-speed optical communication DSP and high-speed SerDes. The company has completed several rounds of financing within half a year, with a C+ round of financing of 200 million yuan, and the investors in this round include Photon Strong Chain Fund, Henglu Asset and many other institutions. Yunxiu Capital acted as the exclusive financial advisor for two consecutive rounds.
IDC: The education and learning market is expected to exceed $150 billion by 2027, making AI a key competitor
With the increasing number of types of smart terminal devices and the integration of functions, the value they carry often spans multiple scenarios. At the same time, the ecology plays an increasingly important role in the development of intelligent terminals, and the development of intelligent terminal devices in terms of connection, interaction and service experience is mutually promoting and supporting each other. Different use scenarios usually bring different emphases of ecological development. Based on this, in order to better understand smart terminal devices, IDC divides the use scenarios of smart terminals into six smart life scenarios, namely leisure and entertainment, mobile office, education and learning, sports and health, home control, and smart travel.
See: https://cn.technode.com/post/2023-08-23/idc-2027-edu-ai/
Technology goes to sea
Furbulous, a brand of pet smart products going overseas, completed the angel + round of financing
Recently, Furbulous, a brand of pet smart products, announced the completion of an angel round + financing, which was invested by Ruihe Capital. It is reported that the financing funds will be used for product research and development, supply chain construction and brand building. Founded in 2022, Furbulous is headquartered in Shanghai with an R&D and innovation center in Suzhou. At present, Furbulous has launched its core product, the smart litter box Furbulous Box, and has made new business progress in Taiwan, the United States and Europe.
Indonesian electric motorcycle company Ilectra received $50 million in Series B funding
Indonesian electric motorcycle company Ilectra Motor Group (IMG) has recently raised $50 million in its Series B funding. It is understood that the financing is led by Horizons Ventures (Victoria Harbor Investment, Li Ka-shing's investment institution), with the participation of Foxconn Co-GP Fund. It is reported that the funds will be used for the expansion and product development of IMG's two-wheel EV brand ALVA in the Indonesian market. IMG, a joint venture between Indonesian energy companies Indika Energy, Alpha JWC Ventures and Horizons Ventures, was founded in 2022 and focuses on the two-wheel EV product area, and IMG has launched two two-wheel EV products under its ALVA brand, ALVA ONE and ALVA CERVO (priced at IDR 36.49 million and IDR 37.75 million respectively, It is about 17,400 and 18,000 yuan, respectively).
Sensor Tower: "Free Fire" topped the global mobile game download list in July with nearly 21 million downloads
According to store intelligence data released by Sensor Tower, Garena's Free Fire (including Free Fire MAX) topped the global mobile game download list in July with nearly 21 million downloads. India is the number one market for the game, contributing 27.7% of downloads; This is followed by Indonesia and Brazil, with 9.4% and 8.3% respectively. On July 7, the game celebrated its 6th anniversary with the launch of the limited-time Craftland game mode every week. Notably, these new modes coincide with their peak in downloads. In addition, players can obtain anniversary items, skins, suits, and more through various events. This series of events further cemented Garena's position as the number one download chart for Free Fire.
See: https://cn.technode.com/post/2023-08-23/sensor-tower-mobile-game-download-top-10-jul-2023/
Pet medicine startup Mixlab completes Series A additional financingPet medicine startup Mixlab completed Series A additional financing, this round led by Vanterra Ventures and participated by Lakehouse Ventures, raising a total of $10 million. So far, Mixlab has raised a total of $40 million. The new funding enables Mixlab to open another division in the Miami area. Mixlab founder and CEO Fred Dijols also plans to use the new funds for product operations and expansion, technology development, and gradually become profitable. Mixlab began operating in New York and Los Angeles two years ago and is dedicated to providing pet prescription and pharmacy services. Mixlab's proprietary technology helps veterinarians write and manage prescriptions digitally, automatically send prescriptions to pet owners via text message, and offer free next-day delivery in all 50 states.
One-click forwarding, poke and see!